Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nurdan, Tozun"'
Autor:
Ramazan Idilman, Homie Razavi, Sarah Robbins-Scott, Ulus Salih Akarca, Necati Örmeci, Sabahattin Kaymakoglu, Bilgehan Aygen, Nurdan Tozun, Rahmet Güner, Hurrem Bodur, Jeffrey V. Lazarus
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study reports new national prevalence
Externí odkaz:
https://doaj.org/article/ee4794e1ef92451a99879ad3fa3dcdf8
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 7, Iss 1, Pp 87-94 (2020)
According to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5%. After FDA approval in 1995, many countries have used standard triple therapy (proton pump inhibitor 40 mg b.i.d clarithromycin 500 mg b.i.d and amoxicillin 1 gr
Externí odkaz:
https://doaj.org/article/3dd5768ee15d4dd091beb75054795619
Autor:
Nurten Turkel Kucukmetin, Bulent Gucyetmez, Tuncer Poyraz, Sadik Yildirim, Gungor Boztas, Nurdan Tozun
Publikováno v:
Case Reports in Gastroenterology, Vol 8, Iss 1, Pp 56-60 (2014)
Smuggling drugs by swallowing or inserting into a body cavity is not only a serious and growing international crime, but can also lead to lethal medical complications. The most common cause of death in ‘body packers', people transporting drugs by i
Externí odkaz:
https://doaj.org/article/0256a0029b9b4a94869ba841689ba7db
Autor:
Billur Canbakan, Hakan Akin, Gulgun Tahan, Orhan Tarcin, Fatih Eren, Ozlen Atug, Veysel Tahan, Nese Imeryuz, Ozlem Yapicier, Erol Avsar, Nurdan Tozun
Publikováno v:
Annals of Hepatology, Vol 8, Iss 3, Pp 234-240 (2009)
Objective. To test the effects of peginterferon in an unrecoverable model of bile-duct ligation (BDL) induced liver fibrosis.Material and methods.Thirty-seven Wistar rats were divided into five groups: group 1, BDL + peginterferon (n = 8); group 2, B
Externí odkaz:
https://doaj.org/article/e98abbcb7b144cfcbae54b537a35e278
Autor:
Sinem Oktem-Okullu, Arzu Tiftikci, Murat Saruc, Bahattin Cicek, Eser Vardareli, Nurdan Tozun, Tanil Kocagoz, Ugur Sezerman, Ahmet Sinan Yavuz, Ayca Sayi-Yazgan
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136212 (2015)
The outcome of H. pylori infection is closely related with bacteria's virulence factors and host immune response. The association between T cells and H. pylori infection has been identified, but the effects of the nine major H. pylori specific virule
Externí odkaz:
https://doaj.org/article/73aea5337d1247de981437b5c1694177
Autor:
Cihan Yurdaydin, Fehmi Tabak, Sabahattin Kaymakoglu, Mesut Akarsu, Esra G. Akinci, Hikmet Akkiz, Canan Alkim, Ayhan H. Cekin, Nefise O. Cuvalci, Kadir Demir, Bulent Degertekin, Ilyas Dokmetas, Galip Ersoz, Kenan Hizel, Fatma O. Kandemir, Yusuf Onlen, Abdullah Sonsuz, Ebubekir Senates, Selma Tosun, Nurdan Tozun, Ramazan Idilman, Viral Hepatitis Guidelines Study Group
Publikováno v:
The Turkish Journal of Gastroenterology. 28:84-89
Publikováno v:
Northern Clinics of Istanbul
İstanbul Kuzey Klinikleri, Vol 7, Iss 1, Pp 87-94 (2020)
İstanbul Kuzey Klinikleri, Vol 7, Iss 1, Pp 87-94 (2020)
According to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5%. After FDA approval in 1995, many countries have used standard triple therapy (proton pump inhibitor 40 mg b.i.d clarithromycin 500 mg b.i.d and amoxicillin 1 gr
Autor:
Fehmi Tabak, Cihan Yurdaydin, Sabahattin Kaymakoglu, Mesut Akarsu, Esra G. Akinci, Hikmet Akkiz, Canan Alkim, Ayhan H. Cekin, Nefise O. Cuvalci, Kadir Demir, Bulent Degertekin, Ilyas Dokmetas, Galip Ersoz, Kenan Hizel, Fatma O. Kandemir, Yusuf Onlen, Abdullah Sonsuz, Ebubekir Senates, Selma Tosun, Nurdan Tozun, Ramazan Idilman, Viral Hepatitis Guidelines Study Group
Dear Colleagues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872bb44454cc321c364660e4eb0ded06
https://avesis.deu.edu.tr/publication/details/87dc861c-a425-487b-9932-7cbb7d51b07d/oai
https://avesis.deu.edu.tr/publication/details/87dc861c-a425-487b-9932-7cbb7d51b07d/oai
Autor:
Veysel, Tahan, Resat, Ozaras, Cetin, Karaca, Suleyman, Uraz, Fatih, Eren, Ahmet, Danalioglu, Erol, Avsar, Salih, Turkoglu, Kenan, Midilli, Fehmi, Tabak, Recep, Ozturk, Ali, Mert, Hakan, Senturk, Nurdan, Tozun
Publikováno v:
Hepato-gastroenterology. 56(94-95)
The management of chronic hepatitis C virus (HCV) infection is costly. Genotyping determines the indication, probability of response, and duration of treatment and the dose of ribavirin. Although genotyping is accepted cost-effective, the cost of gen
Autor:
Nurdan, Tozun, Ozlen, Atug, Nese, Imeryuz, Hulya O, Hamzaoglu, Arzu, Tiftikci, Erkan, Parlak, Ulku, Dagli, Aysel, Ulker, Sadettin, Hulagu, Hale, Akpinar, Candan, Tuncer, Inci, Suleymanlar, Oya, Ovunc, Fatih, Hilmioglu, Serap, Aslan, Kursat, Turkdogan, Halil Ibrahim, Bahcecioglu, Cihan, Yurdaydin, I, Tuncer
Aim To investigate the epidemiologic and clinical characteristics of inflammatory bowel disease (IBD) patients in a large multicenter, countrywide, hospital-based study in Turkey. Materials and methods Twelve centers uniformly distributed throughout
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a73a2fb37adb10dee30b618a8025e4
https://avesis.gazi.edu.tr/publication/details/9fc30355-4afd-4e77-8584-ef6f0dba6272/oai
https://avesis.gazi.edu.tr/publication/details/9fc30355-4afd-4e77-8584-ef6f0dba6272/oai